Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Explore which index funds have the lowest fees to improve retirement planning. Learn how expense ratios impact long-term growth and how to pick cost-efficient options.
27,827 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Redwire posted a strong revenue beat but a bigger-than-expected loss, triggering a mid-day rally in its stock. This a...
A Chinese AI named KIMI is making bold end-2026 forecasts for XRP, Ethereum, and Dogecoin, triggering a fresh wave of...
Blend Labs reports a profitable fourth quarter as a rebound in mortgage activity boosts revenue and renews optimism f...
Bitcoin climbs on rising demand from whales and regulated ETFs, suggesting more upside may be ahead. Here are the key...
Qualcomm is navigating a tough start to 2026. A memory crunch, potential shifts with Apple, and a large buyback are m...
A deep-dive look at electroCore's 2026 earnings narrative. This article unpacks Q1 signals, growth drivers, and pract...
SoundHound AI reported its sixth consecutive earnings beat as revenue and AI platform demand accelerate. The LivePers...
Mind Robotics has rapidly transformed Rivian's focus, reaching a multi-billion dollar valuation. Learn the two key wa...
NVIDIA has redefined its role in the AI era, but the upside isn’t finished. This piece unpack three practical reasons...
As travel recoveries accelerate in 2026, hotels deploy AI to upgrade guest service without losing personal connection...
Broadcom beat on revenue but missed AI-growth expectations, sparking a rethink on how investors price AI-driven momen...